Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Income from Continuing Operations (2016 - 2025)

INVO Fertility (IVF) has disclosed Income from Continuing Operations for 15 consecutive years, with 2644625.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 62.18% to 2644625.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 10969483.0, a 46.9% decrease, with the full-year FY2024 number at 9095838.0, down 13.21% from a year prior.
  • Income from Continuing Operations was 2644625.0 for Q3 2025 at INVO Fertility, down from 12702221.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12702221.0 in Q2 2025 to a low of 17403586.0 in Q1 2025.
  • A 5-year average of 2207502.16 and a median of 2453469.0 in 2021 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: plummeted 2816.08% in 2022, then skyrocketed 665.76% in 2025.
  • INVO Fertility's Income from Continuing Operations stood at 101782.0 in 2021, then tumbled by 2816.08% to 2764478.0 in 2022, then rose by 27.84% to 1994782.0 in 2023, then tumbled by 81.65% to 3623493.0 in 2024, then grew by 27.01% to 2644625.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Income from Continuing Operations are 2644625.0 (Q3 2025), 12702221.0 (Q2 2025), and 17403586.0 (Q1 2025).